Back to People

Jay Roberts has been a senior strategic executive in the healthcare industry for over 30 years. He is serving as a Venture Partner for DigiLife Fund II, leading fundraising, due diligence and investment decisions along with members of the DigiLife team and syndicate investment funds. He currently serves as a member of the Board of Directors for Cingulate (Nasdaq:CING; Clinical Stage – Phase III – Biopharma); Caidya Research (Global CRO).; Veriskin, Inc. (Clinical Stage Cancer Detection Medical Device); NaviPoint Health, Inc. (Commercial Stage Microbiome Test); Vyant Bio, Inc. (Drug Discovery/Biotechnology); and is a member of the Fellows of DIA.

Jay has held Chief Executive Officer, Chief Operating Officer and Chief Financial Officer positions for Nasdaq publicly-traded and venture and private equity backed healthcare technology, diagnostics, software solutions and manufacturing companies throughout a successful industry career; including leading more than 50 M&A and debt and equity transactions.

Until February 2023, Jay was the President and Chief Executive Officer of Vyant Bio, Inc., an innovative biotechnology company reinventing drug discovery for complex neuro-developmental and neuro-degenerative disorders. Jay had previously served as the Chief Executive Officer and Operating Officer of Cancer Genetics. Prior to joining Cancer Genetics, Jay served as the Chief Financial Officer for VirMedica, Inc., an innovative technology solutions company that provides an end-to-end platform that enables specialty-drug manufacturers and pharmacies to optimize product commercialization and management. Before VirMedica, Jay was the Chief Financial and Administrative Officer for AdvantEdge Healthcare Solutions Inc., a global healthcare analytics and services organization. Prior to that, Jay also served as the Chief Financial Officer and Treasurer for InfoLogix, Inc., a publicly-traded, healthcare-centric mobile software and solutions provider. InfoLogix was acquired by Stanley Healthcare (NYSE: SWK), with Jay leading the transaction. He has also held CFO roles at leading public medical device and healthcare services firms including: Clarient, Inc., a publicly-traded provider of diagnostic laboratory services; and Daou Systems, Inc., a publicly-traded healthcare IT software development and services firm. In addition, he has held key senior executive roles with MEDecision, Inc., HealthOnline, Inc., and the Center for Health Information.

Jay formerly was a member of the Board of Directors and Past Chair for the Drug Information Association (DIA), a global neutral forum enabling drug developers and regulators access to education and collaboration. He also served on the Board of Directors for vivoPharm, Pty, Ltd, a holding company of Vyant Bio based in Melbourne, Australia. and is the past Chairman of the Board of Directors for AdvantEdge Healthcare Solutions Private Limited, based in Bangalore, India and a director of Gentris Hong Kong Limited, a global biopharma services company.

Jay is a current member of the Alliance of CEOs based in San Francisco, CA and is a recognized thought leader and is invited to speak and serve as an expert panelist for numerous programs and publications, covering topics related to “conscious capitalism”, leadership and mentoring, corporate finance, mergers and acquisition, capital formation, and innovation related to cancer treatments and the healthcare industry generally.